Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Chadi Al-Nawakil"'
Autor:
Stéphanie Malartre, Cristina Bagacean, Véronique Leblond, Aline Clavert, Hugo Legendre, Caroline Dartigeas, Nanthara Sritharan, Bernard Drenou, Kamel Laribi, Xavier Troussard, Ségolène Brichler, Anne-Sophie Michallet, Driss Chaoui, Alain Delmer, Lise Willems, Christian Puppinck, Cécile Tomowiak, Fatiha Merabet, Damien Roos-Weil, Chadi Al-Nawakil, Florence Cymbalista, Rémi Letestu, Marie C. Béné, Romain Guieze, Vincent Levy, Philippe Genet
Publikováno v:
Blood Advances
Blood Advances, The American Society of Hematology, 2022, 6 (1), pp.207-211. ⟨10.1182/bloodadvances.2021006215⟩
Blood Advances, The American Society of Hematology, 2022, 6 (1), pp.207-211. ⟨10.1182/bloodadvances.2021006215⟩
Immunocompromised individuals such as patients with chronic lymphocytic leukemia (CLL) are at risk of impaired immune responses to vaccination. The objective of our study was to evaluate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8f6ff29fe1b1f71f722a373e71a0ebd
http://europepmc.org/articles/PMC8632355
http://europepmc.org/articles/PMC8632355
Autor:
Damien Roos-Weil, Alain Delmer, Lise Willems, Xavier Troussard, Nanthara Sritharan, Aline Clavert, Anne-Sophie Michallet, Philippe Genet, Hugo Legendre, Cristina Bagacean, Véronique Leblond, Caroline Dartigeas, Kamel Laribi, Bernard Drenou, Fatiha Merabet, Christian Puppink, Vincent Levy, Yamina Touileb, Cécile Tomowiak, Stéphanie Malartre, Rémi Letestu, Driss Chaoui, Florence Cymbalista, Chadi Al Nawakil, Romain Guieze, Marie C. Béné, Ségolène Brichler
Publikováno v:
Blood
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for an ongoing global pandemic. Phase III trials have demonstrated excellent efficacies of mRNA vaccines against SARS-CoV-2 in large population studies (Baden LR, NEJM, 2021;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee938e3ae2920f3a86bdffd36d78210
http://europepmc.org/articles/PMC8701581
http://europepmc.org/articles/PMC8701581
Autor:
Anne Quinquenel, Nadine Varin-Blank, Vincent Levy, Chadi Al Nawakil, Fanny Baran-Marszak, Virginie Eclache, Christine Le Roy, Florence Ajchenbaum-Cymbalista, Rémi Letestu, Alain Delmer, Mohammed Khalloufi, Marouane Boubaya
Publikováno v:
American Journal of Hematology. 90:E5-E8
Only a minority of chronic lymphocytic leukemia (CLL) patients harboring a positive direct antiglobulin test (DAT) will develop autoimmune hemolytic anemia (AIHA). In a single institution cohort of 378 CLL patients, 56 patients (14.8%) had at least o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6da6072106dea654a6b140f62706a475
https://doi.org/10.1002/ajh.23861
https://doi.org/10.1002/ajh.23861
Autor:
Hélène Fontaine, Laurence Moachon, Jerome Tamburini, Philippe Sogni, Lise Willems, Chadi Al-Nawakil, Mona Benm’rad, Cédric Mauprivez, Benoit Terris, Didier Bouscary, Benjamin Laffy
Publikováno v:
Leukemia & Lymphoma. 55:1670-1674
l-asparaginase (L-ase) is a major drug used to treat acute lymphoblastic leukemia (ALL) [1]. L-ase kills leukemic cells by depleting circulating asparagine pools related to its asparaginase activit...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2382797403b5f11ad9b1df6e02ed98b
https://doi.org/10.3109/10428194.2013.845886
https://doi.org/10.3109/10428194.2013.845886
Autor:
Francois Xavier Goudot, Loic Ysebaert, Constantine S. Tam, Vincent Levy, Jehan Dupuis, Chadi Al Nawakil, Anne Quinquenel, Marie Sarah Dilhuydy, Eric Van Den Neste, Christophe Meune, Philip A. Thompson, Anne Sophie Michallet, Florence Cymbalista, Michael J. Keating
Publikováno v:
British journal of haematology. 175(3)
Summary Atrial fibrillation (AF) occurs in 5–9% of patients treated with ibrutinib for chronic lymphocytic leukaemia (CLL); the clinical consequences and optimal management are unclear. We retrospectively studied 56 CLL patients who received ibruti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98abcefb8bc509eca61627ca948afdbc
https://pubmed.ncbi.nlm.nih.gov/27611114
https://pubmed.ncbi.nlm.nih.gov/27611114
Autor:
Alexa S. Green, Norbert Ifrah, François Dreyfus, Catherine Lacombe, Nicolas Chapuis, Patrick Mayeux, Sophie Grabar, Jerome Tamburini, Nabih Azar, Chadi Al-Nawakil, Nathalie Jacque, Sophie Park, Didier Bouscary, Lise Willems, Micheline Tulliez
Publikováno v:
British Journal of Haematology. 156:547-550
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4d3552562d23cfc5a5e23aea27077cd
https://doi.org/10.1111/j.1365-2141.2011.08891.x
https://doi.org/10.1111/j.1365-2141.2011.08891.x
Autor:
Catherine Thieblemont, Marjane Ertault, Patricia Franchi, Cédric de Bazelaire, Eric de Kerviler, Josette Brière, Nathalie Beranger, Chadi Al Nawakil, Pauline Brice, David Sibon
Publikováno v:
British Journal of Haematology. 153:191-198
Summary Around 20% of Hodgkin lymphoma (HL) patients are refractory to first-line therapy with ABVD (adriamycin–bleomycin–vinblastine–dacarbazine) or relapse after complete remission. Salvage regimens frequently have delayed courses or require
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c29c00389af048241d6422460c03ffc
https://doi.org/10.1111/j.1365-2141.2011.08594.x
https://doi.org/10.1111/j.1365-2141.2011.08594.x
Autor:
Chadi Al-Nawakil, Jerome Tamburini, Francois Dreyfus, Farhad Heshmati, Sophie Park, M.C. Quarre, Didier Bouscary, Bénédicte Deau
Publikováno v:
British Journal of Haematology. 161:738-740
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::870840f604642fde54d386a2eaeb0f54
https://doi.org/10.1111/bjh.12284
https://doi.org/10.1111/bjh.12284
Autor:
Thierry Jo Molina, Olivier Hermine, Didier Bouscary, T.-A. Szwebel, Jerome Tamburini, Francois Dreyfus, Laure Gibault, Nicolas Chapuis, Chadi Al-Nawakil, Sophie Park
Publikováno v:
British Journal of Haematology. 156:145-147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d942c921388ae98baace42423dfe17f
https://doi.org/10.1111/j.1365-2141.2011.08825.x
https://doi.org/10.1111/j.1365-2141.2011.08825.x
Autor:
Stephane Vigouroux, Pascaline Talmant, Jean-Luc Harousseau, Chadi Al Nawakil, Patrice Chevallier, Richard Garand
Publikováno v:
Leukemia Research. 32:1001-1003
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2737e149a6911d4d1c48f09fa294b150
https://doi.org/10.1016/j.leukres.2007.11.014
https://doi.org/10.1016/j.leukres.2007.11.014